Clinical Trial: A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Crohn's Disease

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819891) titled 'A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Crohn's Disease' on Feb. 06.

Brief Summary: This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with RO7790121 in participants with moderately to severely active Crohn's disease (CD).

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Moderately to Severely Active Crohns Disease

Intervention: DRUG: RO7790121

RO7790121 will be administered as IV infusion. RO7790121 will be administered as SC injection.

DRUG: Pla...